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Abstract
The traditional method for studying cancer in vitro is to grow immortalized cancer cells in two-dimensional
monolayers on plastic. However, many cellular features are impaired in these artificial conditions, and large changes
in gene expression compared to tumors have been reported. Three-dimensional cell culture models have become
increasingly popular and are suggested to be better models than two-dimensional monolayers due to improved cell-
to-cell contact and structures that resemble in vivo architecture. The aim of this study was to develop a simple high-
throughput three-dimensional drug screening method and to compare drug responses in JIMT1 breast cancer cells
when grown in two dimensions, in poly(2-hydroxyethyl methacrylate) induced anchorage-independent three-
dimensional models, and in Matrigel three-dimensional cell culture models. We screened 102 compounds with
multiple concentrations and biological replicates for their effects on cell proliferation. The cells were either treated
immediately upon plating, or they were allowed to grow in three-dimensional cultures for 4 days before the drug
treatment. Large variations in drug responses were observed between the models indicating that comparisons of
culture model-influenced drug sensitivities cannot be made based on the effects of a single drug. However, we show
with the 63 most prominent drugs that, in general, JIMT1 cells grown on Matrigel were significantly more sensitive to
drugs than cells grown in two-dimensional cultures, while the responses of cells grown in poly(2-hydroxyethyl
methacrylate) resembled those of the two-dimensional cultures. Furthermore, comparing the gene expression profiles
of the cell culture models to xenograft tumors indicated that cells cultured in Matrigel and as xenografts most closely
resembled each other. In this study, we also suggest that three-dimensional cultures can provide a platform for
systematic experimentation of larger compound collections in a high-throughput mode and be used as alternatives to
traditional two-dimensional screens for better comparability to the in vivo state.
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Introduction
The majority of research is carried out using immortalized
cells cultured in two dimensions on plastic, but there is growing
interest in moving to more in vivo-like systems. Three-
dimensional (3D) culture systems are starting to claim this spot
[1]. A wealth of evidence points to the differences in cells
grown in 3D or two-dimensional (2D) culture systems. Cells
grown in 2D monolayers or in 3D cultures have been shown to
have different protein expression profiles [2]. Differential
expression of genes involved in signal transduction [2,3],
cellular movement, cell-to-cell signaling, cellular growth, and
morphology have also been reported [4,5]. For example, cross-
regulation of ß1-integrin and epidermal growth factor receptor
(EGFR) pathways occurs in cells cultured in 3D but not in 2D
[6]. This was also confirmed in vivo using nude mice [7,8]. The
cell culture conditions have also been shown to affect human
epidermal growth factor receptor 2 (HER2) signaling. HER2
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preferentially forms heterodimers in 2D cultures of SKBR3
breast cancer cell whereas 3D culture on poly(2-hydroxyethyl
methacrylate) (polyHEMA) plates promotes HER2
homodimerization [9]. The increased homodimerization in 3D
leads to increased HER2 activation and its localization to
membrane rafts making the cells more sensitive to
trastuzumab. The same study also reported that Akt was
activated in 2D cultures and downregulated in 3D, whereas
MEK1/2 and MAPK levels were increased in 3D. This was also
the case for the breast cancer cell lines BT474 and KPL4 [9].
The Pickl et al. study highlights the importance of using 3D
culture systems when studying HER2-positive breast cancer as
they rely heavily on HER2 and Akt signaling, which are
differentially regulated in 3D versus 2D.
Differences in drug responses between 2D and 3D culture
models have been reported by several laboratories. However,
differences were usually observed using a single drug, which
might show increased sensitivity in either 2D or 3D. For
example, SKBR3 cells grown in 3D polyHEMA cultures are
more responsive to trastuzumab than cells grown in 2D [9], but
more resistant to trastuzumab when grown in Matrigel 3D
cultures [10]. In addition, Weigelt et al. have shown that the
response of the HER2-amplified breast cancer cell lines
SKBR3, AU565, and HCC1569 to anti-HER2 agents
trastuzumab, pertuzumab, and lapatinib was highly cell line
dependent and dependent on whether the cells were cultured
on 3D extracellular matrix gels or in 2D monolayers [10].
Phosphorylation of HER2 was significantly reduced in SKBR3
cells cultured in 3D when compared with cells grown in 2D,
which could explain the differences in drug responses. Li et al.
showed that, in 2D, cell line variants of MCF10 (a normal
human epithelial breast cell line) responded similarly to MEK
inhibition, whereas in 3D, the carcinoma variant of MCF10
became much more sensitive to MEK inhibitors. This was also
observed in MDA-MB-231 (a basal-subtype, breast carcinoma
cell line) [11].
In addition to the drug sensitizing effects in 3D, elevated
chemoresistance to anticancer drugs in 3D models is also very
well characterized [12-15]. Several possible explanations have
been suggested for chemoresistance, including increased pro-
survival signaling in 3D models, upregulation of genes
conferring drug resistance and poor diffusion of drugs.
Variations in drug response in xenografts and 3D and 2D
cultures have also been studied. For example, in a monolayer
culture MGH-U1 (a human bladder carcinoma cell line) cells
are more responsive to the cytotoxic effects of Adriamycin
(doxorubicin) treatment when compared to cells grown as
xenografts or 3D spheroids, most likely due to the poor access
of Adriamycin to the internal cell layers of tumors and 3D
structures [16].
The purpose of this study was to develop a quick and easy-
to-use high-throughput method for drug screening of cells
grown in 3D. In parallel with the method development, the
biological aspect was to compare the drug sensitivities of the
HER2-positive JIMT1 cells grown in 2D and 3D cell culture
conditions, and to determine based on gene expression
patterns which of the cell culture models mimics in vivo tumors
most.
Materials and Methods
Cell culture
JIMT1 (DSMZ GmbH, Germany) is a HER2+, ER-, PR-,
epithelial-like cell line established from the pleural effusion of a
62-year-old woman with trastuzumab-resistant ductal breast
cancer [17]. JIMT1 cells were cultivated in a 1:1 mixture of
Ham’s F-12 + GlutaMAX medium (Gibco Invitrogen, USA) and
Dulbecco’s modified Eagles medium (DMEM, glucose 4.5 g/l;
Sigma Aldrich), with 10% fetal bovine serum (FBS), 2 mM L-
glutamine, 0.01 mg/ml insulin, and 1% penicillin/streptomycin.
850 cells/well were used for the 2D compound screens (2D7d,
7 day culture). DSMZ authenticates all human cell lines by
DNA typing using short tandem repeats and additional
cytogenetic and immunophenotypic tests. Cells were cultured
for a maximum of 30 passages before use.
MCF-7 cells (Interlab Cell Line Collection Italy) were
cultivated in Dulbecco’s modified Eagles medium (DMEM,
glucose 1 g/l; Sigma Aldrich) supplemented with 10% FBS, 2
mM L-glutamine and 1% penicillin/streptomycin.
The Matrigel models
In the MG7d (Matrigel 7 days) model, the compound
libraries, in 100 nl/well, were pipetted to 384-well plates
(Greiner Bio-One, Germany) using an automated liquid
handling station (Hamilton Bonaduz AG, Switzerland). 20 µl of
ice-cold MatrigelTM dilution (1/3 Matrigel (Basement Membrane
Matrix Growth Factor Reduced, BD Biosciences) and 2/3 Opti-
MEM® (Life Technologies)) was transferred to drug plates with
a Multidrop 384 Microplate Dispenser (Thermo Labsystems,
Thermo Electron Corporation, MA) after which the Matrigel was
left to polymerize in a cell culture incubator for 20 minutes. The
Matrigel amount, or the gel thickness, was optimized so that
the cells did not penetrate through the gel and form a 2D
culture on the bottom of the wells in the maximum assay time
of 11 days. Cells in warm culture medium were added on top of
the Matrigel and cultured for the desired time period.
For the MG4+7d (Matrigel 4+7 days) model, the cells were
plated on top of the Matrigel as above for a total of 40 µl. At
day 4, after the cells had formed 3D structures, the automated
liquid handling station was used to pipette the compound
library in 10 µl/well in cell culture medium on top of the cultures.
500 cells/well in a total volume of 50 µl/well were used for both
Matrigel models.
The polyHEMA-induced anchorage-independent 3D
models
384-well plates were coated with 35 µl/well of PolyHEMA
(poly (2-hydroxyethyl methacrylate), Polysciences Inc.), ethanol
(>99%) and sterile water in a 4:90:6 ratio. The plates were left
to dry for 7 days at 37°C. PolyHEMA creates a synthetic
hindrance for the cells and inhibits them from attaching to the
plates [18]. Cells thus form 3D structures by attaching to each
other. For the PH7d (polyHEMA 7 days) model, the compound
libraries were pipetted to the coated plates (10 µl/well), and 40
µl of cell-suspension/well were then added to plates. For the
PH4+7d (polyHEMA 4+7 days) model, the cells were allowed
to grow and form 3D structures for 4 days in the polyHEMA
High-Throughput 3D Screening of JIMT1 Cells
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plate (in 40 µl) before the compounds (10 µl) were added. 5000
cells/well were used for both polyHEMA models.
Cell viability assay
Cell viability was measured with the CellTiter-Glo (CTG,
Promega) luminescent assay using the EnVision Plate Reader
(PerkinElmer Inc.) 45 µl of reagent was used for the 3D
models, and 25 µl for 2D. This disrupted the 3D and 2D
cultures, which was confirmed with microscopic visualization.
No background signal was detected from wells containing only
Matrigel or polyHEMA and culture medium (data not shown).
Caspase-3/-7 activity assays
For caspase-3 and -7 activity measurements, JIMT1 cells
were plated on 384 well plates and grown in 2D, Matrigel, or
polyHEMA for the indicated times. A 1:1 ratio, or 50 µl, of
Caspase-Glo 3/7 reagent (Caspase-Glo 3/7 assay, Promega)
was added to the wells, and the plate was placed on an orbital
shaker for 1hour after which the luminescence was read with
the EnVision Multilabel Plate Reader (PerkinElmer).
Compound screens
The MicroSource cancer compound library consisting of 80
compounds was used (File S1 for annotation). The compounds
and controls were plated in four different concentrations using
the Hamilton robotic liquid handling station. The final
concentration range for the compounds was 0.02, 0.2, 2, and
20 µM per well.
In addition, a 22-drug library consisting mainly of HER2+
cancer-specific drugs was screened using seven
concentrations in two technical replicates (as specified in File
S1). Both libraries were screened three times.
Drugs that induced more than 30% response (decrease in
cell viability) when compared to the controls in any of the five
models were selected for further analysis. Of the 102 drugs, 63
fulfilled these criteria. The loess-log normalized screening data
was expressed drug-wise as the percentage of the lowest
concentration (the two lowest concentrations for the 22-drug
screen due to the lower concentration starting point), and the
63 drug average responses from each model were compared.
Statistical analysis was done using a t-test. No interference
with the 3D sphere formation was observed with any of the
compounds.
Compound screen normalization
Screening data were processed through an automated
analysis work-flow implemented in R that takes in raw HTS
experiment data files from the plate reader along with bar code-
linked, plate-specific annotation files, performs various
normalizations, and generates a comprehensive visual output
as well as interactive Excel files for initial hit finding.
The loess-log normalization algorithm used for this screen is
a novel, statistically more robust, screening data normalization
method that down-weights outliers on the plate before
calculating the loess fit. After loess correction, the data are
normalized to the negative controls and log2-transformed. Data
aggregation was done by fitting a linear model to loess-log-
normalized screening data. The least-squares method is used
to estimate the coefficients. After centering to the plate median,
hits were determined using the RankProd R package [19] by
comparing each 3D condition to the 2D condition and treating
each concentration as an individual origin.
Multiple linear regression (MLR) analysis of the
compound screen data
We performed multiple linear regression analysis comparing
drug responses in 3D models to the 2D model to study
differences in drug responses between the cell culture models
used. These differences were explored using the slope
coefficients (estimates) from the linear regression model. The
estimate shows the rate and direction of the responses
compared to those of the control (2D7d). Cell culture models
with significant (p-value < 0.05) negative estimates were
identified as more sensitive models than the 2D cell culture
model.
Gene expression and xenografts
For the gene expression studies, JIMT1 cells and MCF7 cells
were grown in 6 well plates in a 2D (7d), PH (4 and 7 days), or
MG (4 and 7 days) model. Matrigel was dissolved before RNA
was isolated using Dispase (BD Biosciences). To obtain
xenograft tumors, the fat pads of BALB/c-nude mice were
injected with 1x10-6 JIMT1 cells or MCF7 cells in 25 µl of
medium and 25 µl of Matrigel. The tumors were collected 43
days after injection at 99-158 mm2. Tumor size was calculated
from palpation results using (length/2 x width/2) x π. RNA was
isolated using a mirVana (Life Technologies) kit according to
the manufacturer’s instructions. Gene expression was analyzed
using Illumina HumanHT-12v 4.0 Expression BeadChip (
> 47 000 probes). Two biological replicates were used for
each sample. Gene expression results have been deposited in
the NCBI Gene Expression Omnibus [20] and are accessible
through GEO Series accession number GSE42529 for JIMT1
and GSE47583 for MCF7. Publicly available gene expression
datasets were used for MDA-MB-231 and Hs578T cell lines
(GEO accession number GSE36953).
Hierarchical clustering of the gene expression data was done
using the pvclust R-package using correlation as the distance
parameter and averaging as the clustering method [21].
Ingenuity pathway analysis (IPA) and VENNTURE [22]
programs were used for the data analysis.
Gene expression data normalization
The data were analyzed and visualized using standard and
custom algorithms implemented in the R/BioConductor
framework for statistical computing [23]. Raw data was
transformed using the variance-stabilizing transformation
method described by Lin et al. [24] and implemented in the lumi
package [25]. A linear model was fit to the data and differential
gene expression was assessed by computing empirical Bayes
statistics as implemented in the limma package [26].
High-Throughput 3D Screening of JIMT1 Cells
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Validation of gene expression results
The gene expression levels of 11 genes shown in Table 1
and Table 2 were validated with quantitative RT-PCR using
TaqMan in the JIMT1 cells. In short, total cellular RNAs were
isolated with the RNeasy RNA Isolation kit (Qiagen). Matrigel
was dissolved using Dispase (BD Biosciences) before the RNA
was isolated according to the manufacturer’s instructions. For
cDNA synthesis, 100 ng of total RNA was reverse transcribed
with a High Capacity DNA Reverse Transcription kit (Applied
Biosystems, Foster City, CA, USA). Thereafter, the cDNAs
were diluted 1/10 and TaqMan quantitative real-time-PCR
analysis was conducted with an Applied Biosystems 7900HT
instrument using specific primers for the amplicon genes and
beta-actin designed by the Universal ProbeLibrary Assay
Design Center (Roche Applied Biosciences, Basel,
Switzerland). The sequences of the primers were as follows
(forward, reverse): COL5A1 (cctggatgaggaggtgtttg,
cggtggtccgagacaaag), H19 (ttacttcctccacggagtcg,
gagctgggtagcaccatttc), TAGLN (gtccgaacccagacacaagt,
acccttgttggccatgtct), RARRES1 (cactactacttggcacagctcac,
agtgaatgcgacagggaatta), ALDH1A3 (tggtggctttaaaatgtcagg,
tattcggccaaagcgtattc), ID1 (ccagaaccgcaaggtgag,
ggtccctgatgtagtcgatga), STAT1 (ttggcacctaacgtgctgt,
agttcgtaccactgagacatcct), IFIT1 (agaacggctgcctaatttacag,
gctccagactatccttgacctg), MX1 (cggtcctcagcctggtag,
tgggggtcccgagatatt), OAS2 (cctgcctttaatgcactgg,
atgagccctgcataaacctc), and IFI27 (ccaagcttaagacggtgagg,
ccgtggcctagagagtaagaga). The fluorescent TaqMan probes
were obtained from the Roche Human Probe Library. The
results were analyzed with SDS 2.3 and RQ Manager software
(Applied Biosystems), and mRNA expression was determined
with the relative quantitation method using beta-actin as an
endogenous control. Data were collected from two separate
biological experiments, both of which included four replicates of
two separate RNA samples.
Interferon activity luciferase assays
For the interferon luciferase assays, JIMT1 cells (6000 cells/
well) were plated to 96 well plates and grown for 3 days in 2D
(in 100 µl), Matrigel (50 µl of Matrigel mix + 50 µl of cell mix), or
polyHEMA (in 100 µl) before transfection. On day 3, the cells
were transfected with 20 µl of transfection mix containing 0.3 µl
of Lipofectamine 2000 (Life Technologies) and 100 ng of
reporter plasmid, positive control plasmid or negative control
plasmid/well (Cignal ISRE Reporter Dual-Luciferase Assay kit,
Qiagen) according to the manufacturer’s instructions. On day 4,
STAT1/STAT2-responsive luciferase element activity and the
internal control Renilla activity were measured according to the
manufacturer’s instructions using 90 µl of Dual-Glo reagent and
90 µl of Stop & Glo reagent. Luminescence was read with the
EnVision Multilabel Plate Reader (PerkinElmer).
Ethics statement
The animal study was approved by the Laboratory Animal
Board of Finland (approval number 2008-06166). The study
was conducted at the Turku Center for Disease Modeling.
Ethical guidelines were strictly followed during the animal work.
Results
Setup for high-throughput 3D drug screening
Transitioning from traditional 2D cultures to 3D cultures has
been hampered by the lack of high-throughput assays available
for cells grown in 3D and by the high cost due to the increased
manual labor involved. We were thus interested in developing a
robust and reproducible high-throughput 384-well plate 3D cell
culture drug screening assay that could serve as a model for
other cell lines, tumor types, and co-cultures and that utilizes
automated liquid handling for drug pipetting, cell, and matrix
addition. We set up four 3D cell culture model systems and
compared drug responses in these to the responses of cells
grown in traditional 2D cell culture. The tested 3D culture
conditions were: polyHEMA-coated wells for anchorage-
independent cell growth as a 7 day culture (PH7d), or as a 4 +
7 day culture (PH4+7d) where the cells were first allowed to
form 3D structures for 4 days before addition of drugs, and
Table 1. Top five differentially expressed genes compared
to xenograft.
 
Top 5 upregulated
genes compared
to xenografts
Fold
change
Top 5
downregulated
genes compared
to xenografts
Fold
change
Number of
differentially
expressed
genes, up +
down, ≥ 2 fold
MG4d ALDH1A3 24.7 VIM 54.5 797
 C20orf100 15.2 H19 33.8  
 CALB2 12.7 COL5A1 33.7  
 IL8 11.9 MX1 30.1  
 RARRES1 7.8 PMEPA1 24.5  
MG7d ALDH1A3 29.0 VIM 34.6 473
 RARRES1 28.6 COL5A1 32.4  
 C20orf100 22.8 H19 29.0  
 CALB2 16.2 TAGLN 20.1  
 TOX2 11.0 PMEPA1 19.5  
PH4d RARRES1 62.9 VIM 63.3 760
 S100P 33.4 TGFBI 26.9  
 ID1 25.3 COL5A1 25.9  
 ALDH1A3 15.5 TAGLN 16.2  
 LXN 12.6 H19 15.4  
PH7d RARRES1 75.6 VIM 63.1 952
 LCN2 38.5 TGFBI 33.7  
 S100P 32.6 COL5A1 24.7  
 ID1 26.2 H19 20.2  
 LXN 13.9 TAGLN 19.2  
2D CALB2 23.6 VIM 64.9 2428
 ID1 17.1 H19 27.9  
 ALDH1A3 15.9 COL5A1 26.6  
 LOC100134265 15.5 APOE 13.6  
 RARRES1 13.1 IFIT1 13.5  
Top five up- and downregulated genes and their fold changes in relation to
xenograft expression values are shown. Number of up- and downregulated genes
is largest in the 2D model.
doi: 10.1371/journal.pone.0077232.t001
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Matrigel cultures also for 7 days (MG7d), and 4 + 7 days
(MG4+7d) (Figure 1A). A 7 day 2D culture was used as a
comparison point (2D7d).
The JIMT1 cells grew quite differently in these culture
conditions. The cells grew 1.86-fold faster in Matrigel (MG7d)
than in 2D cultures (2D7d), and 7.2-fold slower in polyHEMA
(PH7d) than in 2D cultures. Thus, the growth rate difference
between polyHEMA and Matrigel was 13.52-fold measured
with the CellTiter-Glo cell viability endpoint reads divided by the
cell number at plating (Figure 1C). In both 3D culture models,
the JIMT1 cells formed mass-shaped spheroids [2] although
they were more uniformly shaped and sized in Matrigel (Figure
1B). PolyHEMA cultures contained more single cells as well as
larger structures. The cell growth rate in the different models
was further analyzed with cell viability growth curves, and
induction of apoptosis was studied by caspase-3/-7 activity
assays, which indicated increased apoptosis in the polyHEMA
cultures (File S2). In addition, a more extensive panel of
Table 2. Top five differentially expressed genes compared
to 2D.
 
Top 5
upregulated
genes
compared to
2D
Fold
change
Top 5
downregulated
genes compared
to 2D
Fold
change
Number of
differentially
expressed
genes, up +
down, ≥ 2 fold
MG4d IL8 14.5 CLIC3 6.6 1842
 NCOA7 7.4 LOC100008589 5.6  
 HSP90AA1 5.9 CLDN7 5.5  
 NUFIP2 5.8 ITGB4 5.4  
 CSE1L 5.8 WNT5B 5.2  
MG7d IL8 9.6 LOC100008589 6.0 2104
 RIOK3 7.1 ID1 5.9  
 TTC3 6.9 GPRC5A 5.8  
 FOSB 6.7 NDUFB9 5.7  
 EIF3E 6.5 SFN 5.0  
PH4d MX1 25.6 KISS1 13.8 755
 IFIT1 24.6 AXL 12.7  
 OAS2 22.7 WNT5B 10.8  
 IFI27 15.2 MARCH4 10.6  
 STAT1 13.0 FJX1 6.5  
PH7d HLA-B 35.2 AXL 16.6 851
 OAS2 28.8 KISS1 16.2  
 IFI27 27.8 MT1A 11.2  
 IFIT1 24.8 MARCH4 10.8  
 MX1 24.3 MT2A 10.3  
Xenograft VIM 64.9 CALB2 23.6 2428
 H19 27.9 ID1 17.1  
 COL5A1 26.6 ALDH1A3 15.9  
 APOE 13.6 LOC100134265 15.5  
 IFIT1 13.5 RARRES1 13.1  
Top five up and downregulated genes and their fold changes in relation to 2D
expression values. Number of up- and downregulated genes is larger in the
xenograft and Matrigel models than in the polyHEMA model.
doi: 10.1371/journal.pone.0077232.t002
representative images in the presence and absence of a drug
is provided in File S3.
Drug screening revealed marked differences between
the cell culture models
To compare drug responses between the different 3D cell
culture conditions, JIMT1 breast cancer cells were screened
with two different drug libraries: a MicroSource cancer
compound library with 80 compounds in four dilutions, each in
one replicate, and a custom 22 compound library mainly
consisting of HER2+ cancer-targeted drugs in seven dilutions,
each in two intra-plate replicates (File S1). All screens were
carried out in three biological replicates.
Interestingly, the cells responded differently to several drugs
in the different cell culture models. Colchicine, a microtubule
polymerization inhibitor traditionally used for treating gout and
currently being investigated for use as an anticancer drug, was
highly effective in inhibiting cell viability in the 2D and Matrigel
models, but the drug showed only moderate effects in the
polyHEMA models (Figure 2).
Methotrexate is an antimetabolite and antifolate drug
developed for use in cancer treatment and for autoimmune
diseases. Methotrexate showed clear growth inhibition in the
Matrigel models but only modest growth inhibition in the 2D
and polyHEMA models (Figure 2). This drug acts on most
rapidly dividing cells and could thus be expected to be most
efficient in the Matrigel models. However, the effect in the
polyHEMA and 2D models was very similar although the
growth rate was 7-fold higher in 2D models (Figure 1C).
Helenine (Alantolactone), an antimycobacterial agent, which
has been hypothesized to inhibit cell proliferation by inducing
activin/SMAD3 signaling [27] inhibited growth in all 3D models
but showed little effect in the 2D models (Figure 2).
In addition, the Akt pathway inhibitor API-2 was clearly most
effective in both polyHEMA models, showed only a minor effect
in Matrigel, and was ineffective in the 2D models (Figure 2).
The API-2 effect was unique among the Akt/PI3k inhibitors
used in the study.
As shown in Figure 2, individual drug responses can differ
greatly among the five different cell culture models and can
show sensitivity advances to any of the models. Therefore,
generalizations of cell culture model-specific drug sensitivities
cannot be made based on effects seen with a single drug. This
has been the case in many previous studies comparing 3D cell
cultures to 2D cultures.
Cells grown in Matrigel are most sensitive to drugs
As our goal was to compare drug effects between the
different cell culture models in general, we combined the
results from both drug screens. Out of 102 drugs, 63 inhibited
cell viability more than 30% in at least one of the models and
were selected for further analysis. The average of the 63 drugs’
three highest concentrations showed that cells in the 2D model
had the smallest response to drugs (81.07% of the control
value). Cells were significantly more responsive to the drugs in
both Matrigel models than in the 2D model with the two highest
concentrations (Figure 3A). Despite the slower growth rate,
cells were slightly more responsive to these drugs in the
High-Throughput 3D Screening of JIMT1 Cells
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Figure 1.  JIMT1 cells form mass-shaped structures in 3D.  A. Time series of JIMT1 cells grown as either a Matrigel (MG) or
polyHEMA (PH) culture. B. Zoom-in representative images of mass-shaped JIMT1 structures in Matrigel and polyHEMA. C. Growth
rate comparison of 2D, Matrigel, and polyHEMA cultures. The growth rate was calculated by dividing the CTG (CellTiter-Glo) read
by the starting cell number and expressed as % of 2D. Pictures were taken with IncuCyte.
doi: 10.1371/journal.pone.0077232.g001
High-Throughput 3D Screening of JIMT1 Cells
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Figure 2.  Drug screening shows differences between the
culture models and responses to individual drugs vary
greatly.  Cells cultured in 2D, Matrigel (MG4+7d, MG7d), or
polyHEMA (PH4+7d, PH7d) were treated with colchicine,
methotrexate, helenine or API-2 with the indicated
concentrations for 7 days. The cells were treated either directly
up on plating for 7 days (2D7d, MG7d, PH7d) or after 4 day
pre-growth at 3D (MG4+7d, PH4+7d). CellTiter-Glo (CTG) was
used as a cell viability measure; data are an average of three
biological replicates. Error bars are STDEV, * indicate
statistically (t-test) significant changes compared to the
corresponding 2D7d concentration, * < 0.05, ** < 0.01, *** <
0.001.
doi: 10.1371/journal.pone.0077232.g002
polyHEMA models than in the 2D model, but the findings were
not statistically significant.
To verify these findings, a separate bioinformatic analysis
was conducted using the raw screening data. In this analysis,
the two drug screens were analyzed separately, and all the
drugs were included. Concentration-wise multiple linear
regression analysis was performed for the MicroSource cancer
compound library screen with 80 compounds. Overall, for every
unit increase in treatment response in the 2D cell culture
model, there was a further increase in response in MG7d
(estimate -0.154, p-value < 0.001) and in MG4+7d (estimate
-0.094, p-value < 0.01). Similarly, in the smaller screen
containing 22 drugs, the analysis showed that cells in MG7d
were significantly more responsive to drugs than in the 2D
model (estimate -0.188, p-value < 0.001) (Figure 3B).
These two independent analyses indicate that JIMT1 cells
are in general more responsive to drugs when grown in
Matrigel than in traditional 2D cultures. However, as shown in
Figure 2, there are some exceptions; therefore, the effects of
individual drugs should not be generalized. The result could
also explain some of the diversity in the literature reporting
sensitizing and desensitizing effects in 3D culture models.
Gene expression patterns of cells grown in Matrigel
cultures are closest to xenografts
Three-dimensional models are considered to resemble in
vivo conditions more than 2D monolayer cultures [28]. To verify
this, we compared the gene expression profiles of all our cell
culture models to the JIMT1 xenograft expression profiles.
JIMT1 cells were injected into the mammary fat pads of mice,
and the tumors were collected 43 days later. To understand the
different models better, we analyzed the gene expression
patterns of 4 day and 7 day old cultures. It takes 4 days for the
cells to form 3D structures. Therefore, we postulated that this
could be a critical time-point to see expression changes
compared to the 2D cultures. Genome-wide gene expression
levels of tumor samples and culture model samples (xenograft,
2D7d, MG4d, MG7d, PH4d, and PH7d) were obtained with
Illumina HumanHT-12 v4 Expression BeadChip. Averages of
duplicate samples were used for data analysis.
Unsupervised hierarchical clustering of the data groups
Matrigel cultures (4 day and 7 day samples) together with the
xenografts, and polyHEMA cultures cluster together with 2D
cultures in a separate branch. The au (approximately unbiased)
and bp (bootstrap probability) p-values for these clusters were
100% for each relation indicating statistically highly significant
differences (Figure 4A). The data indicate that JIMT1 Matrigel
3D cultures resemble xenograft cultures more closely than 2D
or polyHEMA cultures. However, this cannot be generalized.
Similar samples (xenograft, 2D7d, MG4d, MG7d, PH4d, and
PH7d) were prepared from the HER2-negative, ER-positive
breast cancer cell line MCF7. The overall gene expression
changes between the models were minimal, and no co-
clustering of Matrigel samples with xenografts was observed
(GEO accession number GSE47583).
The VENNTURE [22] Venn diagram of the differentially
expressed genes (≥2-fold upregulated) compared to the 2D
culture shows that Matrigel cultures share 472 commonly
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upregulated genes with xenografts whereas polyHEMA
cultures share only 63 commonly upregulated genes with
xenografts (Figure 4B). In addition, the data indicate that cells
in Matrigel continue to differentiate toward a more xenograft-
like signature as the MG7d signature shares 1416 up/
downregulated genes with the xenografts when compared to
the 2D cultures whereas the MG4d model shares 1004 genes
with the xenografts. This was not the case in the polyHEMA
cultures as both PH-profiles shared 515 up/downregulated
Figure 3.  JIMT1 cells are more sensitive to drugs in Matrigel.  A. Average drug response of the JIMT1 cells in different cell
culture models. The average responses of the 63 drugs are shown individually for the three highest concentrations (high (0.34-20
µM), medium (0.034-2 µM), and low (0.0034-0.2 µM) and across the concentrations. Response, p-value, and significance (** < 0.01,
* < 0.05) compared to 2D are shown above the bars and average across the concentrations is shown above the line. Drug
annotations and concentrations used for each drug are shown in File S1. B. Multiple linear regression analysis of individual drug
screens comparing general drug effects to 2D. T-value shows the response difference to 2D (33.46 or 26.06). ***< 0.001, **<0.01,
*<0.05.
doi: 10.1371/journal.pone.0077232.g003
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Figure 4.  Gene expression of JIMT1 cells grown in Matrigel is closest to xenografts.  A. Dendrogram showing hierarchical
clustering of genome-wide gene expression data. au = approximately unbiased p-value (%) in red, bp = bootstrap probability value
(%) in blue, edge = cluster number in gray. Data shown are the average of two biological RNA replicates. Correlation of the
replicates is shown in File S6 B. Venn diagram of ≥2-fold upregulated genes compared to 2D7d shows the number of shared genes
in every combination of culture models. A list of common genes for each category is shown in File S4.
doi: 10.1371/journal.pone.0077232.g004
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genes with the xenografts compared to the 2D cultures (Figure
4B, File S4).
In addition, there were 54 commonly downregulated genes in
the 3D cultures and in the xenografts when compared to 2D.
Ingenuity pathway analysis (IPA) showed that these genes are
involved in ER pathway activation and hepatocyte growth
factor, transforming growth factor, and synovial apoptosis
inhibitor 1 pathway inhibition, indicating that there are
significant changes in hormone and growth factor signaling
when cells are cultured in 2D (files S4 and S5).
Correlation analysis of the genome-wide data shows high
overall correlation of the samples; xenografts had the weakest
correlation with 2D7d (average 0.923), medium correlation with
the polyHEMA models (average 0.951), and the highest
correlation with the Matrigel models (average 0.966) (File S6).
A closer look at the data revealed that the number of
differentially expressed genes (more than 2-fold, up and down)
between the xenografts and the 2D7d was 2428, the
xenografts versus the PH7d was 952, and the xenograft versus
the MG7d was 473 genes (Table 1), indicating that xenografts
had a closer relationship with the Matrigel cultures than to the
others tested.
The most differentially upregulated gene in xenografts
compared to 2D, Matrigel, or polyHEMA was vimentin (64.9-,
34.6- to 54.5-, 63.1- to 63.3-fold expression difference,
respectively), which could indicate an epithelial-to-
mesenchymal transition (EMT) [29]. From the top five
downregulated genes when compared to xenografts, TAGLN
and COL5A1 have also been indicated in EMT [30,31]. The top
five downregulated entries from all the comparisons to
xenografts contained only nine unique genes (APOE, COL5A1,
H19, IFIT1, MX1, PMEPA1, TAGLN, TGFBI, and VIM) (Table
1). Interestingly, most of these genes (COL5A1, H19 PMEPA1,
TAGLN, and VIM) are activated by HER2 signaling according
to IPA. Furthermore, S100P and ID1, which were in the top five
upregulated in polyHEMA and 2D models compared to the
xenografts are downregulated by HER2 signaling (Figure 5).
According to IPA, HER2 is the most significantly changing
upstream regulator in xenografts when compared to the 2D
cultures (p-value 1.15E-13, activation z-score -1.05, File S5)
indicating that although HER2 signaling is only slightly
downregulated in xenografts, it is significantly altered when
compared to traditional 2D cell culture models. The HER2
signaling pathway was also significantly altered in the
polyHEMA and Matrigel 3D cultures compared to the 2D
cultures, indicating that HER2 signaling sensitively changes in
response to differences in the extracellular environment. This is
essential to keep in mind when studying HER2 signaling. IPA
gene expression analysis for changes in upstream signaling
was carried out for three additional cell lines. Statistically
significant changes in HER2 signaling pathway activity
between the xenograft and 2D cultures were also observed in
MCF7 HER2-negative, ER-positive breast cancer cell line and
in the MDA-MB-231 and Hs578T triple negative breast cancer
cell lines (GEO Series accession number GSE47583 for MCF7
and GSE36953 for MDA-MB-231 and Hs578T cell lines).
Interestingly, the most changing pathways in the xenografts
when compared to the 2D cultures were the interferon signaling
and PI3K/Akt pathways (File S5). In addition, the polyHEMA
models had a very clear interferon response with many of the
interferon pathway components highly upregulated compared
to the 2D cultures. Although interferon signaling was also high
in xenografts, it was still markedly higher in polyHEMA (Figure
6, Table 2, File S5). Dual luciferase interferon activity assays
were conducted to validate these findings. The assays showed
significantly increased interferon pathway activation in the
polyHEMA cultures and in the 2D cultures when compared to
the Matrigel cultures (Figure 6B). All of the top five upregulated
genes in PH4d compared to the 2D cultures are part of the
interferon pathway: MX1, IFIT1, OAS2, IFI27, and STAT1
(Figure 6A). In general, all of the 3D and xenograft models
were altered from 2D by differential expression of genes
involved in cellular movement, cell-to-cell signaling and
interactions, and cell death and survival (File S5).
This analysis indicates that the gene expression of cells
grown in Matrigel models most closely resembles the gene
expression of the xenografts. Therefore, the overall drug
response of JIMT1 cells grown in Matrigel cultures is likely to
most accurately represent xenograft drug responses. To
validate the gene expression array results, the RNA expression
levels of 11 genes were determined with TaqMan RT-PCR.
The results clearly supported the array data (File S7).
Changes in the gene expression patterns could also explain
some of the differences in drug responses observed in Figure
2. We showed that helenine, which has been hypothesized to
inhibit cell proliferation by inducing activin/SMAD3 signaling
[27], inhibited growth in all 3D models but showed little effect in
the 2D model (Figure 2). This could possibly be due to
increased SMAD3 signaling dependency in the 3D models as
we observed higher p21 (activated by SMAD3) and lower c-
myc expression levels (inhibited by SMAD3) in the 3D models
compared to the 2D model. The p21 levels were 11% and
162% higher in MG7d and PH7d, respectively, than in the 2D
model whereas c-myc expression was 49% and 45% lower in
MG7d and PH7d, respectively, than in the 2D model (GEO
Series accession number GSE42529 for gene expression
results).
In contrast, we observed that the Akt pathway inhibitor API-2
was clearly the most effective in both polyHEMA models
(Figure 2). This was unexpected as the gene expression
profiling of the polyHEMA model did not indicate activation of
the Akt pathway when compared to either the 2D or Matrigel
model; instead, PTEN was activated with a Z-score of 2.62 (p-
value 2.24E-9) when compared to 2D indicating that the Akt
pathway is inhibited (File S5).
Discussion
The aim of the study was to develop and test various 3D
culture models suitable for high-throughput drug screening
approaches utilizing automated liquid handling as much as
possible to reduce manual labor and human error. Automated
liquid handling was easily adaptable for the 7 day models;
PH7d required the 384 well plates to be pre-coated with
polyHEMA before drug pipetting, and MG7d required the
creation of Matrigel gel on the drug-containing plates before the
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cells were added. Matrigel and the equipment (automated
plate-filler cassettes, cleaning buffers, and plates) had to be
kept ice-cold for the entire procedure to avoid polymerization of
Matrigel to the machines. No Matrigel was added to the culture
medium as is often done [32]; this was left out from the protocol
to avoid unnecessary stress to the cells caused by the ice-cold
medium that would have been needed to add Matrigel.
However, no apparent morphological differences were detected
in our 3D cultures in Matrigel when compared to images of cell
spheres in the literature where additional matrix was used.
The robotic system needed to be adjusted for the 4+7 day
treatments so that the drug libraries could be pipetted on top of
the growing cultures at day 4. In the 4+7d models, cells had
time to form 3D structures before interference with the
compound. The hypothesis was that this model would mimic in
vivo conditions better, as the cells were allowed to form 3D
structures before the drug treatments. However, the 4+7d
model is more laborious and more expensive to carry out than
the 7d model, which is technically more similar to high-
throughput screening of 2D cultures. The gene expression
analysis indicated that the expression profile of cells grown in
Matrigel continues to develop toward a xenograft-like profile as
the longer 7 day cultures shared a larger number of
differentially expressed genes with xenografts than the shorter
4 day cultures when compared to the cells in the 2D cultures.
Interestingly, this was not the case in the polyHEMA cultures.
Furthermore, cells grown in the MG4+7d model were most
different from the 2D model in the overall drug response
Figure 5.  HER2 signaling is altered in xenograft.  The most significantly altered upstream regulator in xenograft compared to 2D
according to IPA; the HER2 pathway with arrows pointing to the top five changing genes shown in Table 1. Genes in red were
upregulated in xenografts, and genes in green were downregulated. The 200 most upregulated and the 200 most downregulated
genes in the xenografts compared to the 2D cultures were subjected to IPA analysis using the log-fold differences in expression as
comparison values.
doi: 10.1371/journal.pone.0077232.g005
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Figure 6.  Interferon pathway is activated in polyHEMA cultures.  A. The canonical pathway that changed the most in PH4d and
in PH7d compared to 2D according to IPA; the interferon pathway with arrows pointing to the top five changing genes in PH4d is
shown in Table 2. Genes in red were upregulated in PH4d. Two hundred of the most up- and downregulated genes in PH4d/PH7d
compared to the 2D cultures were subjected to IPA analysis. B. The gene expression results were validated by measuring
interferon-alpha and beta activity from JIMT1 cells by transfecting them with a Cignal ISRE Reporter dual-luciferase assay kit
(Qiagen). The kit measures induction of the STAT1 and STAT2 components of the JAK/STAT-signal transduction pathways as a
readout for interferon activity. The cells were grown in 2D, MG, or PH for 3 days before reporter plasmids and transfection reagents
were added for 24 hours. *** p-value < 0.001.
doi: 10.1371/journal.pone.0077232.g006
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analysis, thus supporting our hypothesis although there was
only a minor, non-significant, difference from the MG7d model.
All the drug screens were carried out for a minimum of 7 days,
so the potential impact of gene expression changes at the 4
and 7 day time points to drug responses is hard to judge.
Based on the similarities in the drug screening results between
the two Matrigel models and ease of use, we believe the
Matrigel 7 day protocol (MG7d) is the most practical alternative
for JIMT1 high-throughput 3D drug screening. For other cell
lines, the most suitable 3D high throughput approach needs to
be determined case by case.
We also note that the gene expression comparison of
xenografts to cells grown on Matrigel cultures is somewhat
biased as the cells were injected in the fat pads of mice
together with 25 µl of Matrigel to improve the initiation of tumor
growth. However, the tumors were collected 43 days after
inoculation, and the amount of Matrigel at the beginning of the
experiment was so small that it is unlikely to have affected the
tumour gene expression at the end of the experiment.
Our drug screening results show that no general conclusions
on drug sensitivities in different culture conditions can be drawn
based on effects seen with a single drug. This is in line with the
literature; Weigelt et al. have shown that AU565 breast cancer
cells grown in Matrigel cultures are more sensitive to the HER2
inhibitory antibody trastuzumab but less sensitive to HER2
dimerization inhibiting antibody pertuzumab when compared to
the same cells grown in 2D cultures [10]. Others have also
shown that cells cultured in 3D matrices are either sensitized or
desensitized to drug treatment, depending on the cell and/or
drug type [33,34].
However, analysis of the entire screening data clearly
showed with two independent analysis methods that JIMT1
cells are sensitized to drugs when grown in Matrigel cultures.
To our knowledge, this is the first time general drug sensitivities
between cell culture models have been analyzed in a high-
throughput manner. These results support previous discoveries
that the extracellular matrix and microenvironment play a
significant role in cell responses [2,35,36].
Our results indicate that data from 2D drug responses of
JIMT1 cells may not represent the in vivo responses very well
as they differ significantly from the closest in vivo counterpart
for JIMT1 cells tested here, the Matrigel cultures. Three-
dimensional culture models have also been indicated to better
mimic in vivo situations by others; EMT-6 mammary tumor cells
are highly resistant to alkylating agents in vivo and lose their
resistance in traditional 2D monolayers as opposed to 3D
cultures [37]. In addition, the cytotoxic effect of Adriamycin in
the spheroid culture model more closely parallels the in vivo
effect than the monolayer cultures [16]. However, this might not
always be the case. Our examination of the gene expression
patterns of the MCF7 2D, Matrigel, polyHEMA, and xenograft
cultures showed that the differences between the culture
models were much smaller in the MCF7 cells than in the JIMT1
cells indicating that the differences between drug responses
might be much smaller.
As we observed a marked difference in growth rates
between the different culture models tested, one could argue
that the detected differences in drug sensitivities are due to
varying growth rates. However, Heiser et al. studied the effects
of 77 compounds in 50 breast cancer cell lines and concluded
that the drug responses were not strongly influenced by the
growth rates of breast cancer cells [38]. On the contrary, they
observed that half of the luminal breast cancer subtype-specific
compounds were most effective in the most slowly growing
cells. Similarly, comparison of drug responses of fast growing
leukemia cells (L1210) and ten human tumor cell lines (5
melanomas, 4 colon carcinomas and 1 small cell lung
carcinoma) did not show increased resistance in the slower
growing tumor cell lines [39]. Furthermore, if the drug
responses were directly comparable to growth rates, cells
grown in polyHEMA cultures should clearly have been the least
sensitive to drugs in our assays, and that was not the case;
cells grown in 2D cultures were.
It is possible that the growth rate measured by comparing the
starting cell number to the endpoint cell viability is suboptimal
for polyHEMA cultures as the cells were plated in high numbers
and formed tight and large mass-shaped structures. Nutrients
thus might not reach the cells within the center, and the cells
might stay in a quiescent, or even necrotic, state not having
ATP-levels comparable with the proliferating outer layer [5,40].
Mouse mammary tumor cell line spheroids in collagen have
been shown to contain more senescent cells and increased
necrosis compared to monolayer cultures [41]. We found
evidence of increased cell death in the polyHEMA cultures as
we observed higher caspase-3/-7 activity in the polyHEMA
cultures than in the 2D or Matrigel cultures.
Differences in cell number might affect drug responses. For
example, colon cancer cells become more resistant to drugs in
confluence dependent manner [42-44]. This could affect
interpretation of the polyHEMA drug screening data as these
cultures were seeded in a much higher density than 2D and
Matrigel cultures. In addition, serum concentration has been
shown to affect chemosensitivity; ovarian cancer cell line
OVCA433 was clearly more sensitive to 4 cytotoxic drugs (4-
HC, Cisplatin, Paclitaxel, and Topotecan) when cultured in 10%
serum instead of serum free complete assay medium [45]. In
our study, the cells cultured in Matrigel were grown in 6%
serum whereas 2D and polyHEMA cultures had 10% serum.
Based on the Fernando et al. study the difference in serum
concentration would increase the drug sensitivity of 2D and
polyHEMA cultures in respect to Matrigel cultures which was
not the case. Matrigel, although growth factor reduced, does
include similar growth factors and nutrients as serum, and
could thus even out the difference in serum concentration.
As previous studies using single agents have suggested, and
which was confirmed here in JIMT1 breast cancer cells using
63 compounds, cells grown in 3D Matrigel cultures show an
increased responsiveness to anticancer compounds
[2,9-11,46]. The reason is still unclear, but one possible
explanation is tumor heterogeneity; 2D and polyHEMA cultures
might give growth advantage to a more drug resistant cell
population than Matrigel cultures [47]. Another explanation is
that cells in 3D cultures use paracrine mechanisms similar to in
vivo tumors and that these mechanisms do not exist in 2D
monolayers [48]. This is supported by data from our gene
expression arrays; the cytokine IL8 was the most upregulated
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gene in both Matrigel (4 day and 7 day) samples. Interestingly,
IL8 has been linked to a specific “HER2/HER3 signature”
supporting our findings on changes in HER2 pathway activities
in 3D cultures [49]. Notably, examining public datasets
revealed high levels of IL8 transcripts in HER2-enriched as well
as basal-like primary breast tumors, two subtypes
characterized by a particularly poor prognosis. Moreover, IL8
expression correlated with high tumor grade and ER-negative
status.
Naturally, these observations made in JIMT1 breast cancer
cells cannot be directly applied to other cell lines, and the
preferred growth conditions have to be determined cell line by
cell line. Also, changes in drug sensitivity between the culture
models should be tested using additional cell lines to confirm
our findings. Optimally, the observed differences in drug
sensitivities should in parallel be tested in xenografts. However,
this study indicates that JIMT1 cells are most sensitive to drugs
and most equal to in vivo conditions when grown in Matrigel as
3D cultures. Interestingly, significant differences in growth
factor and HER2 signaling were observed between the
xenograft and 2D cultures, pointing to the limitations of the
traditional 2D cell culture method.
Supporting Information
File S1.  Drug screen plate annotations and screening
results. Sheet 1+3: Annotations of 22 drugs and MicroSource
80 compound libraries used in the screens. Sheet 2+4: Loess-
log normalized drug screening results.
(XLSX)
File S2.  Characterization of the models. A. Growth curves of
JIMT1 cells grown as 2D, Matrigel, or polyHEMA cultures.
Median cell viability values (CellTiter-Glo) and STDEV from 16
wells are shown. B. Caspase-3 and -7 activity (Caspase-Glo
3/7 assay, Promega) from 2D, Matrigel (MG), or polyHEMA
(PH) cultures measured at 9 or 13 days of culture. The
averages of six wells with STDEV are shown, p-value < 0.001
for all changes.
(EPS)
File S3.  Representative image of the models.
Representative images of JIMT1 cells in 2D (2D7d), Matrigel
(MG4+7d), or polyHEMA (PH4+7d) cultures grown up to 11
days in the presence or absence of 5 µM API-2. Images are
taken from 384 well plates using IncuCyte (Essen Bioscience).
(TIF)
File S4.  Commonly up- or downregulated genes in each
model. Sheet 1: VENNTURE image of downregulated genes
compared to 2D expression. Sheet 2: VENTURE gene list of
upregulated genes compared to 2D. Sheet 3: VENNTURE
gene list of downregulated genes compared to 2D. Sheet 4:
VENNTURE place code.
(XLSX)
File S5.  IPA pathway analysis of gene expression
changes. Sheet 1: Commonly downregulated genes in all of
the 3D models and xenografts compared to the 2D cultures
Sheet 2: HER2 is the most significantly changing up-stream
regulator in xenografts when compared to 2D. Sheet 3: The
canonical pathways that changed the most in xenografts
compared to 2D cultures: the interferon pathway and the PI3K
pathway. Interferon signaling is upregulated in polyHEMA
cultures compared to xenografts. Sheet 4: Top five changing
molecular and cellular functions. Sheet 5: IPA top changing
upstream regulators in PH7d versus 2D7d. PTEN is
significantly activated in polyHEMA.
(XLSX)
File S6.  Correlation analysis of gene expression profiles.
Sheet 1: Genome-wide Pearson correlation is shown
separately for the two biological repeats.
(XLSX)
File S7.  TaqMan RT-PCR validation of gene expression
results. Gene expression of 11 genes was validated with
TaqMan RT-PCR. A. Genes based on gene expression
analysis were downregulated in the cell culture compared to
xenografts. B. Genes based on gene expression analysis were
upregulated in the cell culture compared to xenografts. C.
Genes based on gene expression analysis were upregulated in
polyHEMA compared to xenografts. D. Genes based on gene
expression analysis were upregulated in polyHEMA compared
to 2D cultures. The data shown are an average of 16 replicates
(two biological replicates each including four repeats of two
RNA replicates).
(EPS)
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